Literature DB >> 19906901

Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Geraint B Rogers1, Stuart Skelton, David J Serisier, Christopher J van der Gast, Kenneth D Bruce.   

Abstract

Sampling of the lower airways of the adult cystic fibrosis (CF) lung has received insufficient detailed consideration, with the importance of sampling strategies for bacteriological outcome not known. Although spontaneously expectorated sputum (SES) samples are often used for diagnostic bacteriological analysis, induced sputum (IS) methods have advantages. This study examined whether significant differences in bacterial content were detected when using a culture-independent, molecular profiling technique to analyze SES or IS samples. Moreover, this work examined what trends relating to bacterial species distributions and reproducibility were found in sequentially induced sputum samples and what implications this has for pathogen detection. Terminal restriction fragment length polymorphism (T-RFLP) analysis was performed on a SES sample and 4 subsequent IS samples taken at 5-min intervals from 10 clinically stable, adult CF patients. This was repeated over 3 sampling days, with variability between samples, induction periods, and sampling days determined. A diverse range of bacterial species, including potentially novel pathogens, was found. No significant difference in bacterial content was observed for either SES or serial IS samples. On average, the analysis of a single sample from any time point resolved approximately 58% of total bacterial diversity achieved by analysis of an SES sample and 4 subsequent IS samples. The reliance on analysis of a single respiratory sample was not sufficient for the detection of recognized CF pathogens in all instances. Close correlation between T-RFLP and microbiological data in the detection of key species indicates the importance of these findings in routine diagnostics for the detection of recognized and novel CF pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906901      PMCID: PMC2812251          DOI: 10.1128/JCM.01324-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

1.  Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis.

Authors:  Scott D Sagel; Marci K Sontag; Jeffrey S Wagener; Robert K Kapsner; Iris Osberg; Frank J Accurso
Journal:  J Pediatr       Date:  2002-12       Impact factor: 4.406

Review 2.  Islands shaping thought in microbial ecology.

Authors:  Christopher J van der Gast
Journal:  Adv Appl Microbiol       Date:  2008       Impact factor: 5.086

3.  Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.

Authors:  Sang Sun Yoon; Robert F Hennigan; George M Hilliard; Urs A Ochsner; Kislay Parvatiyar; Moneesha C Kamani; Holly L Allen; Teresa R DeKievit; Paul R Gardner; Ute Schwab; John J Rowe; Barbara H Iglewski; Timothy R McDermott; Ronald P Mason; Daniel J Wozniak; Robert E W Hancock; Matthew R Parsek; Terry L Noah; Richard C Boucher; Daniel J Hassett
Journal:  Dev Cell       Date:  2002-10       Impact factor: 12.270

4.  Detection of Chlamydia trachomatis by nucleic acid amplification testing: our evaluation suggests that CDC-recommended approaches for confirmatory testing are ill-advised.

Authors:  Julius Schachter; Joan M Chow; Holly Howard; Gail Bolan; Jeanne Moncada
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

5.  Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis.

Authors:  N R Henig; M R Tonelli; M V Pier; J L Burns; M L Aitken
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

6.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction.

Authors:  S D Sagel; R Kapsner; I Osberg; M K Sontag; F J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

7.  Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.

Authors:  L P A McGarvey; K Dunbar; S L Martin; V Brown; J Macmahon; M Ennis; J S Elborn
Journal:  J Cyst Fibros       Date:  2002-12       Impact factor: 5.482

8.  Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.

Authors:  Michael M Tunney; Tyler R Field; Thomas F Moriarty; Sheila Patrick; Gerd Doering; Marianne S Muhlebach; Matthew C Wolfgang; Richard Boucher; Deirdre F Gilpin; Andrew McDowell; J Stuart Elborn
Journal:  Am J Respir Crit Care Med       Date:  2008-02-08       Impact factor: 21.405

Review 9.  Studying bacterial infections through culture-independent approaches.

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  J Med Microbiol       Date:  2009-06-25       Impact factor: 2.472

10.  Studying bacteria in respiratory specimens by using conventional and molecular microbiological approaches.

Authors:  Geraint B Rogers; Thomas W V Daniels; Andrew Tuck; Mary P Carroll; Gary J Connett; Gondi J P David; Kenneth D Bruce
Journal:  BMC Pulm Med       Date:  2009-04-15       Impact factor: 3.317

View more
  25 in total

Review 1.  Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.

Authors:  Geraint B Rogers; Kenneth D Bruce
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

Review 2.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

3.  Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Sally Palser; Sherie Smith; Edward F Nash; Arnav Agarwal; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

4.  Persistency of Pseudomonas aeruginosa in sputum cultures and clinical outcomes in adult patients with cystic fibrosis.

Authors:  A Burkett; K L Vandemheen; T Giesbrecht-Lewis; K Ramotar; W Ferris; F Chan; S Doucette; D Fergusson; S D Aaron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-23       Impact factor: 3.267

5.  Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.

Authors:  Christian Pustelny; Uliana Komor; Vinay Pawar; Anne Lorenz; Agata Bielecka; Annette Moter; Benjamin Gocht; Denitsa Eckweiler; Mathias Müsken; Claudia Grothe; Heinrich Lünsdorf; Siegfried Weiss; Susanne Häussler
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

6.  Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis.

Authors:  Paul C Blainey; Carlos E Milla; David N Cornfield; Stephen R Quake
Journal:  Sci Transl Med       Date:  2012-09-26       Impact factor: 17.956

7.  Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.

Authors:  Franziska A Stressmann; Geraint B Rogers; Erich R Klem; Andrew K Lilley; Scott H Donaldson; Thomas W Daniels; Mary P Carroll; Nilesh Patel; Benjamin Forbes; Richard C Boucher; Matthew C Wolfgang; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

8.  Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.

Authors:  Françoise Botterel; Cécile Angebault; Odile Cabaret; Franziska A Stressmann; Jean-Marc Costa; Frédéric Wallet; Benoit Wallaert; Kenneth Bruce; Laurence Delhaes
Journal:  Mycopathologia       Date:  2017-08-01       Impact factor: 2.574

9.  Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing.

Authors:  D J Serisier; A Tuck; D Matley; M P Carroll; G Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-12       Impact factor: 3.267

Review 10.  Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset.

Authors:  Geraint B Rogers; Lucas R Hoffman; Matt W Johnson; Nicole Mayer-Hamblett; Jürgen Schwarze; Mary P Carroll; Kenneth D Bruce
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.